The global peptide therapeutics market reached a value of US$ 35.9 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 61.9 Billion by 2027, exhibiting a CAGR of 9.42% during 2022-2027. More Info:- https://www.imarcgroup.com/peptide-therapeutics-market

1. Copyright © IMARC Service Pvt Ltd. All Rights Reserved
Global Peptide Therapeutics
Market Research and Forecast
Report 2022-2027
Author: Elena Anderson
Marketing Manager
IMARC Group
© 2022 IMARC All Rights Reserved

2. Report Description
About IMARC Group
International Market Analysis Research and Consulting Group is a leading adviser on
management strategy and market research worldwide. We partner with clients in all regions
and industry verticals to identify their highest-value opportunities, address their most critical
challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological
developments for business leaders in pharmaceutical, industrial, and high technology
organizations. Market forecasts and industry analysis for biotechnology, advanced materials,
chemicals, food and beverage, travel and tourism, nanotechnology and novel processing
methods are at the top of the company’s expertise.
IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and
markets with close cooperation at all levels of the client organization. This ensures that our
clients achieve unmatchable competitive advantage, build more proficient organizations, and
secure lasting results.

3. Report Description
Report Description and Highlights
Global Peptide Therapeutics Market Research Report 2022-2027:
According to the latest report by IMARC Group, titled "Peptide Therapeutics Market: Global
Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027," the global peptide
therapeutics market reached a value of US$ 35.9 Billion in 2021.
Peptides refer to naturally occurring, short chains of amino acid monomers that are connected with
cell surface receptors for triggering intracellular effects. They are extremely small, versatile, and offer
higher efficacy than other clinical practices; therefore, they are extensively used for engineering
novel regenerative medications as they can target varying cells and manipulate their reactions.
Along with this, peptide therapeutics are non-toxic, well-tolerated, and offer anti-inflammatory
properties, which help in improving the immune system, repairing muscle tendons, and acting as an
antioxidant for treating several metabolic disorders. Consequently, they are being employed for
managing cancer, injuries, aesthetic concerns, and multiple infectious diseases.
Request for a PDF sample of this report: https://www.imarcgroup.com/peptide-therapeutics-
market/requestsample

4. Report Description
Report Description and Highlights
Global Peptide Therapeutics Market Trends:
With the increasing prevalence of various chronic and metabolic disorders, especially amongst the
geriatric population, there has been a rising need for effective medications, which in turn, has facilitated
the widespread adoption of peptide therapeutics across the healthcare sector for treatment purposes.
Additionally, the rising consciousness amongst consumers regarding their physical appearance has
supplemented the utilization of peptide therapeutics in cosmeceutical surgeries as they slow down the
aging process, which is acting as another growth-inducing factor. In line with this, extensive investments
being made by governments of several countries in pharmaceutical companies to develop innovative
novel peptide medications and synthetic strategies to improve product stability are contributing to the
market growth.
Moreover, escalating awareness amongst individuals regarding the availability of personalized medicines
and the ongoing clinical trials by healthcare professionals to develop and execute precise non-invasive
treatment procedures to treat autoimmune and inflammatory diseases are impelling the market
growth. Other factors, such as the significant expansion in the healthcare infrastructure and continuous
research and development (R&D) activities to engineer multi-purpose peptide-based materials, are
creating a positive outlook for the market.

5. Report Description
Report Description and Highlights
Looking forward, IMARC Group expects the market to reach a value of US$ 61.9 Billion by 2027,
exhibiting at a CAGR of 9.42% during 2022-2027.
View Report TOC, Figures and Tables: https://www.imarcgroup.com/peptide-therapeutics-market

6. Report Description
Report Description and Highlights
Key Market Segmentation
The research report includes the following segments:
Breakup by Type:
•Innovative
•Generic
Breakup by Type of Manufacturer:
•Outsourced
•In-house
Breakup by Synthesis Technology:
•Solid Phase Peptide Synthesis
•Liquid Phase Peptide Synthesis
•Hybrid Technology
Breakup by Routes of Administration:
•Parenteral
•Oral
•Others

7. Report Description
Report Description and Highlights
Breakup by Application:
•Gastrointestinal Disorders
•Neurological Disorders
•Metabolic Disorders
•Cancer
•Others
Breakup by Region:
•North America
•Asia Pacific
•Europe
•Latin America
•Middle East and Africa

8. Report Description
Report Description and Highlights
Competitive Landscape with Key Players:
•Amgen Inc
•Apitope International NV
•Arch Biopartners Inc
•AstraZeneca plc
•Circle Pharma Inc
•Corden Pharma GmbH
•F. Hoffmann-La Roche AG
•Ipsen Group
•Lonza Group AG
•Novo Nordisk A/S
•Pfizer Inc
•Teva Pharmaceuticals Industries Ltd
•Zealand Pharma A/S

9. Report Description
Key Questions Answered in the Report
1. How has the global peptide therapeutics market performed so far and how will it perform in the
coming years?
2. What has been the impact of COVID-19 on the global peptide therapeutics market?
3. What are the key regional markets?
4. What is the breakup of the market based on the type?
5. What is the breakup of the market based on the type of manufacturer?
6. What is the breakup of the market based on the synthesis technology?
7. What is the breakup of the market based on the routes of administration?
8. What is the breakup of the market based on the application?
9. What are the various stages in the value chain of the industry?
10. What are the key driving factors and challenges in the industry?
11. What is the structure of the global peptide therapeutics market and who are the key players?
12. What is the degree of competition in the industry?

10. Report Description Table of Contents
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Peptide Therapeutics Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

11. Report Description Table of Contents
6 Market Breakup by Type
6.1 Innovative
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Generic
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Type of Manufacturer
7.1 Outsourced
7.1.1 Market Trends
7.1.2 Market Forecast
7.1 In-house
7.1.1 Market Trends
7.1.2 Market Forecast
8 Market Breakup by Synthesis Technology
8.1 Solid Phase Peptide Synthesis
8.1.1 Market Trends
8.1.2 Market Forecast
Click here to visit the complete table of content with list of figures and tables:
https://www.imarcgroup.com/peptide-therapeutics-market/toc

12. A partial List of our Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
Partial List of Clients

13. A partial List of our Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
Partial List of Clients

14. Report Description
Report Description and Highlights
© 2022 IMARC All Rights Reserved
This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of
International Market Analysis Research and Consulting (IMARC). No part of this publication may be
reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be
used in any form or by and means graphic electronic or mechanical, including photocopying, recording,
taping or by information storage or retrieval, or by any other form, without the express consent of
International Market Analysis Research and Consulting (IMARC).
Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been
based on information and sources believed to be accurate and reliable at the time of publishing.
International Market Analysis Research and Consulting makes no representation of warranty of any kind as to
the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any
loss or damage resulting from opinion, errors or inaccuracies if any found this publication.
IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market
Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of
their respective companies.

15. FOR MORE DETAILS
Visit us at :
Stay With Us:
TELEPHONE: +1-631-791-1145
E-MAIL: sales@imarcgroup.com
https://www.imarcgroup.com
Contact Us